TD Ameritrade Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-41
Closed -$2K 72
2023
Q2
$2K Hold
41
﹤0.01% 443
2023
Q1
$1K Sell
41
-185
-82% -$6.09K ﹤0.01% 534
2022
Q4
$7K Sell
226
-34
-13% -$1.02K ﹤0.01% 413
2022
Q3
$6K Sell
260
-14
-5% -$462 ﹤0.01% 412
2022
Q2
$9K Sell
274
-57
-17% -$2.1K ﹤0.01% 438
2022
Q1
$10K Hold
331
﹤0.01% 496
2021
Q4
$11K Buy
+331
New +$10.3K ﹤0.01% 473
2019
Q3
Sell
-206
Closed -$5K 638
2019
Q2
$5K Buy
206
+66
+47% +$1.95K ﹤0.01% 482
2019
Q1
$5K Buy
140
+39
+39% +$1.42K ﹤0.01% 437
2018
Q4
$3K Buy
+101
New +$3.19K ﹤0.01% 495

Other funds holding CC

TD Ameritrade Investment Management's CC Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Chemours (CC) in Q3 2023, closing a stake of 41 shares — an estimated $2K sold.

TD Ameritrade Investment Management first reported a position in CC in Q4 2018 and held it in 10 quarters. The position peaked at $11K in Q4 2021. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 41 Chemours shares in Q3 2023, an estimated $2K.
  • TD Ameritrade Investment Management first reported a position in Chemours in Q4 2018 and held it in 10 quarters.
  • TD Ameritrade Investment Management's Chemours position peaked at $11K in Q4 2021.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.